Clinical Trial Update: Safety Study of Three Formulations of the Dermal Implant ELAPR [Phase 1]

View source ↗

Summary

This update summarizes safety data from a Phase 1 study evaluating three formulations of the dermal implant ELAPR.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatologic Diseases

Drugs mentioned

• ELAPR

Snippet

Sponsor: Elastagen Pty Ltd | Conditions: Skin Conditions | Phase 1 | Status: COMPLETED